Pay in 4 interest-free payments of $5.52 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Rights and permissions About this article Cite this article Sergi, G., Pizzato, S., Piovesan, F
In markets where there is state/PMI reimbursement of GLP-1 treatment for obesity (eg the US), retatrutide is likely to be reserved as a second-line GLP-1 for those who have failed to lose sufficient weight with a cheaper alternative (such as semaglutide or tirzepatide)
Stubleski J, Salihovic S, Lind PM, et al
Timelines vary based on the specific peptide, your health status, and protocol adherence
US$ 25.58
US$ 20.92
US$ 22.73
US$ 29.15
US$ 23.09
US$ 29.25
US$ 20.48
